{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:56:57Z","timestamp":1790373417283,"version":"4.1.0"},"reference-count":86,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T00:00:00Z","timestamp":1531958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Technology"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    To evaluate the potential for drug interactions with oral inhaled medications (OIMs). OIMs include bronchodilators (\u03b2-agonists and antimuscarinics), corticosteroids, combination products (2 or more agents combined within a single inhalation device), antibiotics, prostacyclins, anesthetics, acetylcysteine, mucolytics, insulin, antivirals, nitric oxide, and nicotine replacement.\n                    <jats:bold>Data Sources:<\/jats:bold>\n                    A systemic literature search (1980 to May 2018) was performed using PubMed and EBSCO to locate relevant articles. The MESH terms used included each specific medication available as an OIM as well as \u201cdrug interactions.\u201d DAILYMED was used for product-specific drug interactions.\n                    <jats:bold>Study Selection and Data Extraction:<\/jats:bold>\n                    The search was conducted to identify drug interactions with OIMs. The search was limited to those articles studying human applications with OIMs and publications using the English language. Case reports, clinical trials, review articles, treatment guidelines, and package labeling were selected for inclusion.\n                    <jats:bold>Data Synthesis:<\/jats:bold>\n                    Primary literature and package labeling indicate that OIMs are subject to pharmacokinetic and pharmacodynamics interactions. The most frequently identified clinically significant drug interaction is an inhaled corticosteroid when combined with a potent CYP 450 inhibitor such as a protease inhibitor or antifungal.\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    The available literature indicates that OIMs are associated with clinically significant drug interactions and subsequent adverse reactions. Clinicians in all practice settings should be mindful of this potential to minimize adverse effects and optimize therapy.\n                  <\/jats:p>","DOI":"10.1177\/8755122518788809","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T09:18:22Z","timestamp":1531991902000},"page":"273-280","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":22,"title":["Drug Interactions With Oral Inhaled Medications"],"prefix":"10.1177","volume":"34","author":[{"given":"Chanelle M.","family":"Ajimura","sequence":"first","affiliation":[{"name":"PPGY1 Pharmacy Practice Resident Providence Portland, Medical Center, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Jagan","sequence":"additional","affiliation":[{"name":"Creighton University, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee E.","family":"Morrow","sequence":"additional","affiliation":[{"name":"Creighton University, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Malesker","sequence":"additional","affiliation":[{"name":"Creighton University, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,7,19]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01892.x"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1998.tb03830.x"},{"key":"e_1_3_2_4_2","unstructured":"Proair HFA [package insert]. Horsham PA: Teva Respiratory LLC; 2012."},{"key":"e_1_3_2_5_2","unstructured":"Albuterol Sulfate [package insert]. Orlando FL: Nephron Pharmaceuticals Corporation; 2009."},{"key":"e_1_3_2_6_2","unstructured":"Proventil HFA [package insert]. Whitehouse Station NJ: Merck & Co Inc; 2014."},{"key":"e_1_3_2_7_2","unstructured":"Ventolin HFA [package insert]. Research Triangle Park NC: GlaxoSmithKline; 2014."},{"key":"e_1_3_2_8_2","unstructured":"ProAir RespiClick [package insert]. Horsham PA: Teva Respiratory LLC; 2016."},{"key":"e_1_3_2_9_2","unstructured":"Xopenex HFA [package insert]. Marlborough MA: Sunovion Pharmaceuticals Inc; 2012."},{"key":"e_1_3_2_10_2","unstructured":"Xopenex [package insert]. Marlborough MA: Sepracor Inc; 2002."},{"key":"e_1_3_2_11_2","unstructured":"Serevent Diskus [package insert]. Research Triangle Park NC: GlaxoSmithKline; 2016."},{"key":"e_1_3_2_12_2","unstructured":"Perforomist [package insert]. Morgantown WV: Mylan; 2013."},{"key":"e_1_3_2_13_2","unstructured":"Brovana [package insert]. Marlborough MA: Sunovion Pharmaceuticals Inc; 2014."},{"key":"e_1_3_2_14_2","unstructured":"Arcapta Neohaler [package insert]. Marlborough MA: Sunovion Pharmaceuticals Inc; 2017."},{"key":"e_1_3_2_15_2","unstructured":"Striverdi Respimat [package insert]. Ridgefield CT: Boehringer Ingelheim Pharmaceuticals Inc; 2014."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0371-4."},{"key":"e_1_3_2_17_2","unstructured":"Ipratropium Bromide [package insert]. Orlando FL: Nephron Pharmaceuticals Corporation; 2005."},{"key":"e_1_3_2_18_2","unstructured":"Atrovent HFA [package insert]. Ridgefield CT: Boehringer Ingelheim Pharmaceuticals Inc; 2012."},{"key":"e_1_3_2_19_2","unstructured":"Clinical Resource Drugs with anticholinergic activity. Pharmacist\u2019s Letter\/Prescriber\u2019s Letter. August 2017. http:\/\/therapeuticresearch.com\/pl\/ArticleDD.aspx?cs=&s=PL&pt=2&fpt=31&dd=330810&pb=PL&searchid=63985267&segment=11399."},{"key":"e_1_3_2_20_2","unstructured":"Spiriva HandiHaler [package insert]. Ridgefield CT: Boehringer Ingelheim Pharmaceuticals Inc; 2016."},{"key":"e_1_3_2_21_2","unstructured":"Spiriva Respimat [package insert]. Ridgefield CT: Boehringer Ingelheim Pharmaceuticals Inc; 2017."},{"key":"e_1_3_2_22_2","unstructured":"Tudorza Pressair [package insert]. Wilmington DE: AstraZeneca Pharmaceuticals LP; 2015."},{"key":"e_1_3_2_23_2","unstructured":"Incruse Ellipta [package insert]. Research Triangle Park NC: GlaxoSmithKline; 2017."},{"key":"e_1_3_2_24_2","unstructured":"Seebri Neohaler [package insert]. East Hanover NJ: Novartis Pharmaceuticals Corporation; 2015."},{"key":"e_1_3_2_25_2","unstructured":"Lonhala Magnair [package insert]. Marlborough MA: Sunovion Pharmaceuticals Inc; 2017."},{"key":"e_1_3_2_26_2","unstructured":"Combivent Repimat [package insert]. Ridgefield CT: Boehringer Ingelheim Pharmaceuticals Inc; 2016."},{"key":"e_1_3_2_27_2","unstructured":"DuoNeb [package insert]. Napa CA: Dey LP; 2009."},{"key":"e_1_3_2_28_2","unstructured":"Anoro Ellipta [package insert]. Research Triangle Park NC: GlaxoSmithKline; 2017."},{"key":"e_1_3_2_29_2","unstructured":"Stiolto Respimat [package insert]. Ridgefield CT: Boehringer Ingelheim Pharmaceuticals Inc; 2016."},{"key":"e_1_3_2_30_2","unstructured":"Utibron Neohaler [package insert]. Marlborough MA: Sunovion Pharmaceuticals Inc; 2017."},{"key":"e_1_3_2_31_2","unstructured":"Bevespi Aerosphere [package insert]. Wilmington DE: AstraZeneca Pharmaceuticals LP; 2016."},{"key":"e_1_3_2_32_2","unstructured":"Pulmicort Respules [package insert]. Wilmington DE: AstraZeneca Pharmaceuticals LP; 2010."},{"key":"e_1_3_2_33_2","unstructured":"Pulmicort Flexhaler [package insert]. Wilmington DE: AstraZeneca Pharmaceuticals LP; 2016."},{"key":"e_1_3_2_34_2","unstructured":"Flovent Diskus [package insert]. Research Triangle Park NC: GlaxoSmithKline; 2017."},{"key":"e_1_3_2_35_2","unstructured":"Flovent HFA [package insert]. Research Triangle Park NC: GlaxoSmithKline; 2017."},{"key":"e_1_3_2_36_2","unstructured":"ArmonAir RespiClick [package insert]. Frazer PA: Teva Respiratory LLC; 2017."},{"key":"e_1_3_2_37_2","unstructured":"Arnuity Ellipta [package insert]. Research Triangle Park NC: GlaxoSmithKline; 2016."},{"key":"e_1_3_2_38_2","unstructured":"Asmanex Twisthaler [package insert]. Whitehouse Station NJ: Merck & Co Inc; 2014."},{"key":"e_1_3_2_39_2","unstructured":"Asmanex HFA [package insert]. Whitehouse Station NJ: Merck & Co Inc; 2016."},{"key":"e_1_3_2_40_2","unstructured":"QVAR [package insert]. Frazer PA: Teva Respiratory LLC; 2017."},{"key":"e_1_3_2_41_2","unstructured":"Alvesco [package insert]. Marlborough MA: Sunovion Pharmaceuticals Inc; 2013."},{"key":"e_1_3_2_42_2","unstructured":"Aerospan HFA [package insert]. St. Louis MO: Forest Pharmaceuticals Inc; 2006."},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-211080."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00416-13."},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12039."},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831090-00005"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2006.0117."},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2015.36.3876."},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1432."},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP13122.CR."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2011.011408."},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.111315."},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2009.009339."},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q103."},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00579.x."},{"key":"e_1_3_2_56_2","unstructured":"Advair Diskus [package insert]. Research Triangle Park NC: GlaxoSmithKline; 2017."},{"key":"e_1_3_2_57_2","unstructured":"Advair HFA [package insert]. Research Triangle Park NC: GlaxoSmithKline; 2017."},{"key":"e_1_3_2_58_2","unstructured":"AirDuo RespiClick [package insert]. Frazer PA: Teva Respiratory LLC; 2017."},{"key":"e_1_3_2_59_2","unstructured":"Breo Ellipta [package insert]. Research Triangle Park NC: GlaxoSmithKline; 2017."},{"key":"e_1_3_2_60_2","unstructured":"Symbicort [package insert]. Wilmington DE: AstraZeneca Pharmaceuticals LP; 2017."},{"key":"e_1_3_2_61_2","unstructured":"Dulera [package insert]. Whitehouse Station NJ: Merck & Co Inc; 2017."},{"key":"e_1_3_2_62_2","unstructured":"Trelegy Ellipta [package insert]. Research Triangle Park NC: GlaxoSmithKline; 2017."},{"key":"e_1_3_2_63_2","unstructured":"TOBI [package insert]. East Hanover NJ: Novartis Pharmaceuticals Corporation; 2015."},{"key":"e_1_3_2_64_2","unstructured":"Bethkis [package insert]. Woodstock IL: Chiesi USA Inc; 2017."},{"key":"e_1_3_2_65_2","unstructured":"Kitabus Pak [package insert]. Midlothian VA: PARI Respiratory Equipment Inc; 2014."},{"key":"e_1_3_2_66_2","unstructured":"TOBI Podhaler [package insert]. East Hanover NJ: Novartis Pharmaceuticals Corporation; 2015."},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201310-352OC"},{"key":"e_1_3_2_68_2","unstructured":"Cayston [package insert]. Foster City CA: Gilead Sciences Inc; 2014."},{"key":"e_1_3_2_69_2","unstructured":"Coly-Mycin M Parenteral [package insert]. Bristol TN: Monarch Pharmaceuticals Inc; 2006."},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.30.12.1279."},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.30.6.562."},{"key":"e_1_3_2_72_2","unstructured":"Amikacin sulfate [package insert]. North Wales PA: Teva Pharmaceuticals USA Inc; 2017."},{"key":"e_1_3_2_73_2","unstructured":"Ventavis [package insert]. South San Francisco CA: Actelion Pharmaceuticals US Inc; 2009."},{"key":"e_1_3_2_74_2","unstructured":"Tyvaso [package insert]. Research Triangle Park NC: United Therapeutics Corp 2016."},{"key":"e_1_3_2_75_2","unstructured":"Flolan [package insert]. Research Triangle Park NC: GlaxoSmithKline; 2008."},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v5.i4.87."},{"key":"e_1_3_2_77_2","unstructured":"Suprane [package insert]. Deerfield IL: Baxter Healthcare Corporation; 2017."},{"key":"e_1_3_2_78_2","unstructured":"Forane [package insert]. Deerfield IL: Baxter Healthcare Corporation; 2010."},{"key":"e_1_3_2_79_2","unstructured":"Ultane [package insert]. North Chicago IL: Abbott Laboratories; 2003."},{"key":"e_1_3_2_80_2","unstructured":"Acetylcysteine [package insert]. Lake Forest IL: Hospira Inc; 2018."},{"key":"e_1_3_2_81_2","unstructured":"Pulmozyme [package insert]. South San Francisco CA: Genentech Inc; 2014."},{"key":"e_1_3_2_82_2","unstructured":"Afrezza [package insert]. Danbury CT: MannKind Corporation; 2014."},{"key":"e_1_3_2_83_2","unstructured":"NebuPent [package insert]. Lake Zurich IL: Fresenius Kabi; 2016."},{"key":"e_1_3_2_84_2","unstructured":"Virazole [package insert]. Bridgewater NJ: Valeant Pharmaceuticals North America LLC; 2016."},{"key":"e_1_3_2_85_2","unstructured":"INOmax [package insert]. Hazelwood MO: Mallinckrodt Pharmaceuticals; 2015."},{"key":"e_1_3_2_86_2","unstructured":"Nicotrol [package insert]. New York NY: Pharmacia & Upjohn Co; 2016."},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181de0acf."}],"container-title":["Journal of Pharmacy Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/8755122518788809","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/8755122518788809","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/8755122518788809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:28:28Z","timestamp":1777602508000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/8755122518788809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,19]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1177\/8755122518788809"],"URL":"https:\/\/doi.org\/10.1177\/8755122518788809","relation":{},"ISSN":["8755-1225","1549-4810"],"issn-type":[{"value":"8755-1225","type":"print"},{"value":"1549-4810","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,19]]}}}